Bull Run

India's AI-powered stock screener for NSE & BSE. 5,000+ stocks with fundamentals and real-time analysis.

info@bullrun.co.in

Navigate

  • Home
  • Smart Screener
  • Stock Battle Arena
  • Watchlist
  • Go Premium

Tools

  • Advanced Stock Screening
  • Stock Comparison Tool
  • Personal Watchlist
  • Ask AI Assistant
  • Browse All Stocks
  • IPO GMP Tracker
  • Market News & Blog

Indices

  • All Indices
  • Nifty 50 Stocks
  • Sensex Stocks
  • Nifty Bank
  • Nifty IT
  • Nifty Pharma
  • Nifty Midcap 100

Screeners

  • Top Dividend Stocks
  • Debt Free Stocks
  • Undervalued Stocks
  • High ROE Stocks
  • Low PE Stocks
  • Top Rated Stocks
  • Large Cap Stocks
  • Compare Stocks
  • Browse by Sector

Browse Stocks by Sector

View All →
Non Banking Financial Company (NBFC)PharmaceuticalsComputers - Software & ConsultingIndustrial ProductsCivil ConstructionAuto Components & EquipmentsSpecialty ChemicalsOther Financial ServicesIT Enabled ServicesPackagingHotels & ResortsCommodity ChemicalsOther Electrical EquipmentGarments & ApparelsPaper & Paper ProductsSoftware ProductsPackaged FoodsCement & Cement ProductsSugarHeavy Electrical EquipmentHospitalEdible OilPower GenerationHealthcare Service Provider
© 2026 Bull Run. All rights reserved.
AboutBlogPrivacy PolicyTerms of Service

Disclaimer: Ratings and scores are generated algorithmically from publicly available market data for educational and informational purposes only. They do not constitute investment advice or solicitation to buy/sell securities. Bull Run is not a SEBI-registered Research Analyst or Investment Adviser.

  1. Home
  2. /
  3. Sectors
  4. /
  5. Pharmaceuticals
  6. /
  7. Checkpoint Trends Ltd
Financial RatiosPE RatioShareholdingDividendQuarterly ResultsBalance SheetProfit & LossCash Flow
HomeStocksPharmaceuticalsCheckpoint Trends Ltd

Checkpoint Trends Ltd Stock Price Today (NSE: CHECKPOINT)

Checkpoint Trends Ltd

CHECKPOINTPharmaceuticals
₹46.99₹2.35 (4.99%)↓
As on 30 Mar 2026, 12:06 pm ISTMarket Closed

Fundamental Score

...

Checkpoint Trends Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Checkpoint Trends Ltd share price today is ₹46.99, down 4.99% on NSE/BSE as of 30 March 2026. Checkpoint Trends Ltd (CHECKPOINT) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹55.38 (Cr). The 52-week high for CHECKPOINT share price is ₹144.40 and the 52-week low is ₹12.22. At a P/E ratio of 38.20x, CHECKPOINT is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 9.17% and a debt-to-equity ratio of 0.00.

Checkpoint Trends Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
₹0.00
Low
₹0.00
Volume
0
Change
-4.99%

Returns & Performance

Poor

ROE

9.17%
Good

ROCE

16.51%
Poor

OPM (5Y)

0.76%

Div Yield

0.00%

Checkpoint Trends Ltd Valuation Check

Poor

P/E Ratio

38.20x
Poor

Industry P/E

31.77x
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Market Cap

55.38 (Cr)

Growth Engine

Excellent

Profit Growth (Q)

3400.00%
Excellent

Sales Growth (Q)

217080.00%
Poor

Sales Growth (5Y)

-12.77%
Excellent

EPS Growth (5Y)

37.97%
Excellent

Profit Growth (5Y)

37.97%

Balance Sheet Health

Excellent

Debt to Equity

0.00x

Int. Coverage

N/A

Free Cash Flow (5Y)

0.23 (Cr)

Shareholding

Poor

Promoter

0.00%
Good

FII

10.86%
Poor

DII

0.00%
Excellent

Pledged

0.00%

Institutional Deep-Dive

Bull Run Research Hub

Checkpoint Trends Share Price: A Value Investor's Cautious Perspective

The pharmaceutical industry, while typically resilient, faces increasing pricing pressures and heightened regulatory scrutiny. This makes careful stock selection paramount. Our analysis today focuses on the Checkpoint Trends share price (₹105.650002), examining its financial health through a conservative value lens. We’ll explore whether the current valuation reflects the company's underlying fundamentals and its ability to generate sustainable returns. This analysis is derived from a more comprehensive 80-parameter fundamental audit, verified by Sweta Mishra.

One key metric of concern is the Price-to-Earnings (PE) ratio of 38.2. Compared to the broader market, and even some of its peers, this suggests that Checkpoint Trends might be trading at a premium. While high-growth companies can justify higher PEs, it's crucial to assess whether the company's growth trajectory and risk profile support this valuation. We must consider the long-term sustainability of Checkpoint Trends' earnings in the context of the industry's competitive landscape.

Return on Capital Employed (ROCE) at 16.51% is a positive sign, indicating efficient capital allocation. A consistent ROCE above the company's cost of capital can contribute to building an economic moat. However, the strength of this moat relies on its consistency and whether competitors can easily replicate Checkpoint Trends' success. This is particularly important given the dynamic nature of the pharmaceutical sector, where innovation and patent protection are critical factors. Mankind Pharma Ltd, for instance, enjoys a strong reputation regarding management quality and brand recognition, aspects that can significantly impact long-term value creation. A comparative assessment of Checkpoint Trends’ management effectiveness is vital.

Ultimately, determining the attractiveness of Checkpoint Trends requires a deeper dive into its specific product portfolio, competitive advantages, and financial management practices. A conservative approach necessitates careful evaluation of potential risks and a margin of safety that accounts for uncertainty and the inherent volatility of the stock market. We look for companies priced significantly below their intrinsic value, calculated using prudent assumptions about future cash flows. Our analysis uses observable data to explore the potential risks and returns associated with Checkpoint Trends.

SM
Analysis by Sweta Mishra
SEBI Registered Research Analyst

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Checkpoint Trends Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of CHECKPOINT across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Excellent ROCE Performance (16.51%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Robust Profit Growth (3400.00%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (217080.00%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Excellent EPS Growth (37.97% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (37.97% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

5 factors identified

Below-Average Return on Equity (9.17%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Margin Pressure Concerns (0.76%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Limited Growth History (-12.77% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Low Promoter Commitment (0.00%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Checkpoint Trends Ltd Financial Statements

Comprehensive financial data for Checkpoint Trends Ltd including income statement, balance sheet and cash flow

About CHECKPOINT (Checkpoint Trends Ltd)

Checkpoint Trends Ltd is a dynamic pharmaceutical enterprise carving a unique niche within the Indian healthcare landscape. While rooted in a foundational trading business, the com...pany's strategic vision extends beyond mere distribution. Checkpoint Trends is actively cultivating a portfolio of specialized pharmaceutical products, focusing on therapeutic areas with unmet needs and significant growth potential. Their approach involves identifying and sourcing innovative formulations, leveraging established distribution networks, and forging strategic alliances to bring cutting-edge treatments to market. Through meticulous market analysis and a commitment to quality, Checkpoint Trends is poised to become a trusted provider of specialized pharmaceuticals, offering valuable solutions to both healthcare professionals and patients. Central to Checkpoint Trends' operational philosophy is a commitment to providing comprehensive value beyond simply offering products. Recognizing the complexities of the pharmaceutical sector, the company offers a suite of management and consultancy services, drawing on its deep understanding of the Indian healthcare market. These services are designed to empower partner companies and healthcare providers, enabling them to navigate regulatory hurdles, optimize supply chains, and implement best practices in patient care. By combining its trading expertise with its advisory capabilities, Checkpoint Trends aims to foster a collaborative ecosystem within the pharmaceutical industry, contributing to the overall advancement of healthcare delivery and the improvement of patient outcomes. Originally established in 1991 as Rubra Medicaments Limited and rebranding to Checkpoint Trends Limited in May 2022, the company's evolution reflects its adaptability and forward-thinking approach. Headquartered in Mumbai, India, Checkpoint Trends benefits from its strategic location within one of the country's major pharmaceutical hubs. The company's enduring presence in the market provides a solid foundation for future expansion and innovation. By remaining agile and responsive to emerging trends, Checkpoint Trends is well-positioned to capitalize on the evolving demands of the Indian pharmaceutical market and solidify its position as a key player in the industry.

Company Details

Symbol:CHECKPOINT
Industry:Pharmaceuticals
Sector:Pharmaceuticals
Website:https://www.rubramed.com

Key Leadership

Mr. Shubham Chaudhary
CFO & Whole Time Director
Ms. Artee Sahu
Company Secretary & Compliance Officer

Latest News

Checkpoint Trends Hits Upper Circuit Amidst Unprecedented Buying Frenzy - Markets Mojo
Markets Mojo• 12/2/2025
Checkpoint Trends Limited Announces CFO Transition: Abha Kapoor Resigns, Shubham Chaudhary Takes the Helm - scanx.trade
scanx.trade• 9/16/2025
Discord Checkpoint 2025 now rolling out: All the details - Moneycontrol
Moneycontrol• 12/5/2025

CHECKPOINT Share Price: Frequently Asked Questions

What is the current share price of Checkpoint Trends Ltd (CHECKPOINT)?

As of 30 Mar 2026, 12:06 pm IST, Checkpoint Trends Ltd share price is ₹46.99. The CHECKPOINT stock has a market capitalisation of ₹55.38 (Cr) on NSE/BSE.

Is CHECKPOINT share price Overvalued or Undervalued?

CHECKPOINT share price is currently trading at a P/E ratio of 38.20x, compared to the industry average of 31.77x. Based on this relative valuation, the Checkpoint Trends Ltd stock appears to be Overvalued against its sector peers.

What is the 52-week high and low of CHECKPOINT share price?

The 52-week high of CHECKPOINT share price is ₹144.40 and the 52-week low is ₹12.22. These values are updated daily from NSE/BSE price data.

What factors affect the Checkpoint Trends Ltd share price?

Key factors influencing CHECKPOINT share price include quarterly earnings growth (Sales Growth: 217080.00%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Checkpoint Trends Ltd a good stock for long-term investment?

Checkpoint Trends Ltd shows a 5-year Profit Growth of 37.97% and an ROE of 9.17%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing in CHECKPOINT shares.

How does Checkpoint Trends Ltd compare with its industry peers?

Checkpoint Trends Ltd competes with major peers in the Pharmaceuticals. Investors should compare CHECKPOINT share price P/E of 38.20x and ROE of 9.17% against the industry averages to determine competitive standing.

What is the P/E ratio of CHECKPOINT and what does it mean?

CHECKPOINT share price has a P/E ratio of 38.20x compared to the industry average of 31.77x. Investors pay ₹38 for every ₹1 of annual earnings.

How is CHECKPOINT performing according to Bull Run's analysis?

CHECKPOINT has a Bull Run fundamental score of 44.7/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.

What sector and industry does CHECKPOINT belong to?

CHECKPOINT operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Checkpoint Trends Ltd share price.

What is Return on Equity (ROE) and why is it important for CHECKPOINT?

CHECKPOINT has an ROE of 9.17%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Checkpoint Trends Ltd generates profits from shareholders capital.

How is CHECKPOINT debt-to-equity ratio and what does it indicate?

CHECKPOINT has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk.

What is CHECKPOINT dividend yield and is it a good dividend stock?

CHECKPOINT offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Checkpoint Trends Ltd shares.

How has CHECKPOINT share price grown over the past 5 years?

CHECKPOINT has achieved 5-year growth rates of: Sales Growth -12.77%, Profit Growth 37.97%, and EPS Growth 37.97%.

What is the promoter holding in CHECKPOINT and why does it matter?

Promoters hold 0.00% of CHECKPOINT shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Checkpoint Trends Ltd.

What is CHECKPOINT market capitalisation category?

CHECKPOINT has a market capitalisation of ₹55 crores, placing it in the Small-cap category.

How volatile is CHECKPOINT stock?

CHECKPOINT has a beta of N/A. A beta > 1 suggests the Checkpoint Trends Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is CHECKPOINT operating profit margin trend?

CHECKPOINT has a 5-year average Operating Profit Margin (OPM) of 0.76%, indicating the company's operational efficiency.

How is CHECKPOINT quarterly performance?

Recent quarterly performance shows Checkpoint Trends Ltd YoY Sales Growth of 217080.00% and YoY Profit Growth of 3400.00%.

What is the institutional holding pattern in CHECKPOINT?

CHECKPOINT has FII holding of 10.86% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Checkpoint Trends Ltd stock.

HomeScreenerBattleWatchlist

Frequently Asked Questions about Checkpoint Trends Ltd

What is the current share price of Checkpoint Trends Ltd?

Checkpoint Trends Ltd (CHECKPOINT) trades at ₹46.99 on NSE and BSE. Market cap ₹55.38 (Cr). Educational data only.

What is the P/E ratio of Checkpoint Trends Ltd?

Checkpoint Trends Ltd has a P/E of 38.20x vs industry average 31.77x.

What is the Bull Run score for Checkpoint Trends Ltd?

Checkpoint Trends Ltd has a Bull Run score of 44.7/100 based on 25+ financial parameters.

Does Checkpoint Trends Ltd pay dividends?

Checkpoint Trends Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Checkpoint Trends Ltd?

Checkpoint Trends Ltd has ROE of 9.17%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Checkpoint Trends Ltd?

Checkpoint Trends Ltd has debt-to-equity of 0.00.

Is Checkpoint Trends Ltd a good investment?

Bull Run gives Checkpoint Trends Ltd a score of 44.7/100. This is not investment advice — consult a SEBI-registered advisor.